NLS Pharmaceutics Ltd. Insider Trading
NCEL
Insiders bought 375K on the open market and sold nothing.
Get an email when NCEL's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Apr 27 | Olivier Samuel Director | Bought | 81,818 | $2.75 | 225K | New | Form 4 |
| Apr 27 | Michel Revel CSO and Director | Bought | 54,545 | $2.75 | 150K | 6.0% | Form 4 |
- Apr 27Olivier SamuelDirector · bought 81,818 at $2.75225KNew position
- Apr 27Michel RevelCSO and Director · bought 54,545 at $2.75150K6.0% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Biotechnology · Pick stocks to compare with NCEL
Spot a number that looks wrong?
Download this analysis as a PDF (Pro)
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing NCEL
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.